Previous 10 | Next 10 |
BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma , Inc. (“AzurRx” or the “Company”) ( NASDAQ: AZRX ), a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) disease...
BOCA RATON, Fla., July 27, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) d...
3 Hot Biotech Penny Stocks to Watch in 2021 Biotech penny stocks are heating up, and it doesn’t look like the momentum is going anywhere anytime soon. The momentum around penny stocks in the biotech industry began early last year as the pandemic set in. And while it started w...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We’re getting off on the right foot this week with a look at the biggest pre-market stock movers for Monday! Source: Shutterstock Chinese education stocks make up much of today’s ...
Shares of AzurRx BioPharma Inc. (NASDAQ:AZRX) traded today at $0.54, breaking its 52-week low. So far today approximately 513,000 shares have been exchanged, as compared to an average 30-day volume of 893,000 shares. AzurRx BioPharma Inc is a development stage biopharmaceutical company. ...
AzurRx BioPharma's (AZRX) underwriter has agreed to increase the size of the previous public offering to ~9.1M common shares to be priced at $0.55/share.Expected gross proceeds are ~$5M.Underwriter's over-allotment is an additional ~1.4M shares.Net proceeds will be used for milestone payments...
BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) d...
BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) d...
AzurRx BioPharma Inc. (NASDAQ:AZRX) traded today at a new 52-week low of $0.64. So far today approximately 231,000 shares have been exchanged, as compared to an average 30-day volume of 947,000 shares. AzurRx BioPharma Inc is a development stage biopharmaceutical company. The company is ...
NEW YORK, July 16, 2021 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street / Newsmax TV announces its TV airing of this weeks’, Sunday, July 18, 2021, broadcasting line-up of its national syndicated 1- hour show, 10-11AM ET. New to The Street’s ...
News, Short Squeeze, Breakout and More Instantly...
AzurRx BioPharma Inc. Company Name:
AZRX Stock Symbol:
NASDAQ Market:
AzurRx BioPharma Inc. Website:
BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (G...
Why Investors Are Watching These 3 Penny Stocks Right Now There are plenty of ways to find the best penny stocks to buy right now. And, one method that many penny stocks investors use is looking at what top investors are buying alongside other metrics. While this can be a good strat...
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastroint...